-activated voltage-dependent K ϩ channels (Slo1, KCa1.1, Maxi-K, or BK channel) play a crucial role in controlling neuronal signaling by coupling channel activity to both membrane depolarization and intracellular Ca 2ϩ signaling. In mammalian brain, immunolabeling experiments have shown staining for Slo1 channels predominantly localized to axons and presynaptic terminals of neurons. We have developed anti-Slo1 mouse monoclonal antibodies that have been extensively characterized for specificity of staining against recombinant Slo1 in heterologous cells, and native Slo1 in mammalian brain, and definitively by the lack of detectable immunoreactivity against brain samples from Slo1 knockout mice. Here we provide precise immunolocalization of Slo1 in rat brain with one of these monoclonal antibodies and show that Slo1 is accumulated in axons and synaptic terminal zones associated with glutamatergic synapses in hippocampus and GABAergic synapses in cerebellum. By using cultured hippocampal pyramidal neurons as a model system, we show that heterologously expressed Slo1 is initially targeted to the axonal surface membrane, and with further development in culture, become localized in presynaptic terminals. These studies provide new insights into the polarized localization of Slo1 channels in mammalian central neurons and provide further evidence for a key role in regulating neurotransmitter release in glutamatergic and GABAergic terminals.
composed of tetramers of pore-forming, and voltage-and Ca 2ϩ -sensing, Slo1 (KCa1.1) ␣ subunits (the product of the KCNMA1 gene), with or without auxiliary transmembrane ␤ subunits (Orio et al., 2002) . Slo1-containing channels contribute to diverse aspects of neuronal function, including neurotransmitter release, afterhyperpolarizations, and repolarization (Sah and Faber, 2002) . Alternative splicing of KCNMA1 transcripts can generate a large number of distinct Slo1 polypeptides, including 16 known Slo1 isoforms in rat and mouse (NCBI Entrez Protein Database, October 2005), many of which exhibit distinct functional characteristics (Shipston, 2001; Fury et al., 2002; Chen et al., 2005) . Activity of Slo1-containing channels can be further modulated by dynamic changes in phosphorylation state (Weiger et al., 2002) , and splicing at particular sites can influence the extent and nature of such modulation (Tian et al., 2001; Zhou et al., 2001 ). Consequently, Slo1-containing channels represent fundamental yet highly variable and dynamic regulators of membrane excitability.
There are several reports of Slo1 localization in brain using rabbit polyclonal antibodies (Table 1) raised against synthetic peptides (Knaus et al., 1996; Hu et al., 2001; Grunnet and Kaufmann, 2004; Martin et al., 2004) or fusion proteins (Sausbier et al., 2004) corresponding to segments from the Slo1 ␣ subunit intracellular C-terminus. The results obtained in these studies are consistent in showing Slo1 staining in brain regions rich in axons and presynaptic terminals, a localization that has also been verified at the electron microscope level, at least in hippocampal CA3 pyramidal cell Schaffer collateral presynaptic terminals (Hu et al., 2001 ). However, in some reports (e.g., Grunnet and Kaufmann, 2004; Martin et al., 2004 ) the Slo1 ␣ subunit has also been described as having an extensive somatodendritic localization. To confirm and extend these studies, we generated anti-Slo1 mouse monoclonal antibodies (mAbs), since 1) they provide continuous and consistent supply of mAbs and thus consistent results, 2) they can have greater specificity over polyclonal antibodies, and 3) the concentration of antibodies can be easily controlled to achieve the highest sensitivity and the lowest background. Here we provide detailed analyses of Slo1 localization in rat and mouse brain by using a specific mAb generated against Slo1, whose specificity was validated by a number of assays, including a lack of detectable immunoreactivity against samples from Slo1 knockout mice. We also characterize the localization of exogenously expressed Slo1 ␣ subunits in hippocampal neurons developing in culture that exhibit a prominent localization of Slo1 in axons and presynaptic terminals.
MATERIALS AND METHODS

Monoclonal antibody production
L6/60 mAbs against the Slo1 channel ␣ subunit were raised against a GST-mSlo1 fusion protein corresponding to amino acids 690 -1196 of mSlo1. Note that positions given here differ from those reported in Pyott et al. (2004) to unambiguously correspond to amino acid positions of the original mSlo cDNA MBR5, Access. No. AAA39746 (Butler et al., 1993) , now referred to as mouse KCMA1 isoform 2 in the KCMA1 protein reference sequence accession Q08460. The amino acid numbering of reference sequence AAA39746 will be used throughout this report. Hybridomas secreting L6/60 mAbs were generated as described previously (Bekele-Arcuri et al., 1996) . Hybridoma clones were screened by chemiluminescence enzymelinked immunosorbant assay (ELISA) against COS-1 cells expressing full-length human Slo1 (Meera et al., 1997) , and then further selected based on immunofluorescence staining of COS-1 cells transfected with the same human Slo1 cDNA. The original ELISA assay yielded 77 positives, of which 53 replicated in the COS immunofluorescence staining. Further screening of these 53 positive clones revealed 14 that yielded single Slo1-sized bands on immunoblot analyses of adult rat brain membrane fractions, and 19 that yielded acceptable immunoperoxidase staining of rat brain sections. Of these, L6/60 (of mouse IgG 2a subtype) was chosen for the studies below. The binding site of L6/60 was further defined by ELISA and immunoblots as being located within amino acids 690 -891 of mSlo1 (Access. No. AAA39746; Butler et al., 1993) .
Other antibodies used in this study
Trimmer lab antibodies. K14/16: described in detail in Bekele-Arcuri et al. (1996) . Mouse monoclonal IgG2b antibody generated against a recombinant GST fusion protein (GST-RAK) containing amino acids 428 -499 of rat Kv1.2. Binding site subsequently mapped to within amino acids [463] [464] [465] [466] [467] [468] [469] [470] [471] [472] [473] [474] [475] [476] [477] [478] [479] [480] . No crossreactivity against other Kv1 family members (Kv1.1, Kv1.3, Kv1.4, Kv1.5, and Kv1.6 overexpressed in heterologous cells) (Bekele-Arcuri et al., 1996) . Immunoblots yield a major population of Kv1.2 with processed N-oligosaccharides and a minor population with high mannose oligosaccharides (Bekele-Arcuri et al., 1996; Shi et al., 1999) . Immunoblot staining eliminated by preincubation with GST-RAK (Bekele-Arcuri et al., 1996) . Staining pattern in brain sections (Bekele-Arcuri et al., 1996; Rhodes et al., 1997; Monaghan et al., 2000) consistent with published Veh et al., 1995) and unpublished (K.J. Rhodes) in situ hybridization data, and with published light and electron microscopic level reports of Kv1.2 localization (McNamara et al., 1993; Wang et al., 1993 Wang et al., , 1994 . K13/31: described in detail in Bekele-Arcuri et al. (1996) . Mouse monoclonal IgG1 antibody generated against a synthetic peptide (Kv1.4N) corresponding to amino acids 13-37 of rat Kv1.4, identical to that used previously to generate a specific anti-Kv1.4 rabbit polyclonal antibody . No crossreactivity against other Kv1 family members (Kv1.1, Kv1.2, Kv1.3, Kv1.5, and Kv1.6 overexpressed in heterologous cells) (Bekele-Arcuri et al., 1996) . Immunoblots yield a major population of Kv1.4 with processed N-oligosaccharides, and a minor population with high mannose oligosaccharides (Bekele-Arcuri et al., 1996; Shi et al., 1999) . Immunoblot staining eliminated by preincubation with Kv1.4N peptide (Bekele-Arcuri et al., 1996) . Staining pattern in brain sections (Bekele-Arcuri et al., 1996; Rhodes et al., 1997; Monaghan et al., 2000) consistent with published (Veh et al., 1995) and unpublished (K.J. Rhodes) in situ hybridization data, and with published light and electron microscopic level reports of Kv1.4 localization Maletic-Savatic et al., 1995; Cooper et al., 1998) . K28/43: described in detail in Tiffany et al. (2000) and Rasband et al. (2002) . Mouse monoclonal IgG2a antibody generated against a recombinant GST fusion protein (GST-KAP1.13) containing amino acids 77-299 of human PSD-95, identical to that used previously to generate a specific anti-PSD-95 guinea pig polyclonal antibody (Kim et al., 1995) . No crossreactivity against other membraneassociated guanylate kinases (SAP97, Chapsyn-110, SAP102 overexpressed in heterologous cells) (Rasband et al., 2002) . Immunoblot staining eliminated in a transgenic mouse expressing a truncated version of PSD-95 (Rasband et al., 2002) . Staining pattern in brain sections (Rasband et al., 2002) consistent with published light and electron microscopic level reports of PSD-95 localization Peterson et al., 2003) . K89/41: Mouse monoclonal IgG1 antibody generated against a synthetic peptide (KC) corresponding to amino acids 837-853 of rat Kv2.1, identical to that used to generate Kv2.1-specific polyclonal antibodies (Trimmer, 1991; Hwang et al., 1993) . Immunoblots yield a single Kv2.1 band (Misonou et al., 2004) . Staining pattern in brain sections (Misonou et al., 2004 ) consistent with published (Drewe et al., 1992) and unpublished (K.J. Rhodes) in situ hybridization data, and with published light and electron microscopic level reports of Kv2.1 localization ( (Trimmer, 1991; Hwang et al., 1993; Maletic-Savatic et al., 1995; Rhodes et al., 1997; Du et al., 1998; Monaghan et al., 2000) . L11A/41: described in detail in Schafer et al. (2004) . Mouse monoclonal IgG1 antibody generated against a recombinant GST fusion protein containing amino acids 1066 -1174 of rat neurofascin-155 (NF-155), and common to NF-186. Recognizes both major splice variants of neurofascin (NF-155, NF186) on immunoblots. Preincubation of L11A/41 with the immunizing fusion protein abolished all immunoreactivity (Schafer et al., 2004) . Staining pattern in brain sections consistent with that of a combination of NF-155 (Collinson et al., 1998) and NF-186 (Davis et al., 1996) . KC: described in detail in Trimmer (1991) . Rabbit polyclonal affinity-purified antibody generated and affinity purified against a synthetic peptide (KC) corresponding to amino acids 837-853 of rat Kv2.1, identical to that used to generate another Kv2.1-specific polyclonal antibody (Hwang et al., 1993) . No crossreactivity against Kv2.2 (Lim et al., 2000) . Immunoblots yield a single Kv2.1 band (Trimmer, 1991; Shi et al., 1999) . Immunoblot staining eliminated by preincubation with KC peptide (Trimmer, 1991) . Staining pattern in brain sections (Trimmer, 1991; Maletic-Savatic et al., 1995; Rhodes et al., 1997; Monaghan et al., 2000) consistent with published (Drewe et al., 1992) and unpublished (K.J. Rhodes) in situ hybridization data, and with published light and electron microscopic level reports of Kv2.1 localization (Hwang et al., 1993; Du et al., 1998) .
Antibodies obtained from other sources. Calbindin D-28K (Sigma C9848, St. Louis, MO). Mouse monoclonal IgG1 antibody generated against purified bovine kidney calbindin-D. Does not react with other members of the EF-hand family, such as calbindin-D-9K, calretinin, myosin light chain, parvalbumin, S-100a, S-100b, S-100A2 (S100L), and S-100A6 (calcyclin).
GluR1 (Upstate Biotechnology 07-660, Lake Placid, NY). Rabbit protein A purified polyclonal antibody generated against a synthetic peptide corresponding to amino acids 276 -287 of rat glutamate receptor 1 (GluR1). Yields a single 106-kD band on immunoblots of rat brain microsomal membranes.
MAP2 (Sigma M1406). Mouse monoclonal IgG1 antibody generated against purified bovine MAP2 (Binder et al., 1986) . Recognizes an epitope on the high molecular weight MAP2 forms, MAP2a and MAP2b, and shows no reaction with the low molecular weight MAP2c or other microtubule proteins.
Myc 1-9E10 (ATCC CRL-1729, American Type Culture Collection, Rockville, MD). Mouse monoclonal IgG1 antibody generated against a synthetic peptide (peptide G) corresponding to amino acids 408 -432 of human p62 c-myc (Evan et al., 1985) . The antibody precipitates the human c-myc protein, but does not react with mouse or chicken c-myc.
Synapsin I (Sigma S193). Rabbit polyclonal affinitypurified antibody generated against purified bovine brain synapsin I. Strongly reacts with synapsin Ia and Ib (De Camilli et al., 1983) .
Tau (Chemicon International, Temecula, CA, Mab3420, clone Tau-1, PC1C6). Mouse monoclonal IgG2a antibody generated against purified denatured bovine brain microtubule associated proteins (Binder et al., 1985) . Recognizes all known electrophoretic species of tau in human, rat, and bovine brain (Szendrei et al., 1993) .
Neuronal culture
Dissociated cultures of embryonic rat hippocampal neurons were prepared as previously described (Banker and Cowan, 1977; Misonou et al., 2004; Misonou and Trimmer, 2005) . Briefly, hippocampi from 18-or 19-day rat embryos were dissociated by treatment with trypsin (0.25% w/v) for 15 minutes at 37°C followed by triturating with a constricted Pasteur pipette. The cells were diluted in modified Eagle's medium (Invitrogen, La Jolla, CA) containing 10% (v/v) horse serum, 0.06% (v/v) glucose and plated on 22-mm 2 coverslips coated with 1 mg/ml poly-L-lysine. After 4 hours, when the cells were adhered to the substrate, the coverslips were transferred into 6-well tissue culture plates that contained a confluent layer of astrocytes prepared from cerebral hemispheres of neonatal rat pups in serum-free modified Eagle's medium with N2 supplements, 0.1% (w/v) ovalbumin, and 0.1 mM sodium pyruvate (Banker and Cowan, 1977) . After 3 days, 1 M cytosine arabinoside was added to inhibit proliferation of nonneuronal cells. Cultures were kept at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . Neurons cultured for 8 days were transfected with human Slo1 cDNA with an extracellular Myc tag (Hf1) (Meera et al., 1997) using Lipofectamine2000 (Invitrogen) as described (Lim et al., 2000) .
Immunostaining of rat brain sections
All animal use procedures were in strict accordance with the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health. Rats were anesthetized with 60 mg/Kg pentobarbital (intraperitoneal, i.p.) and briefly perfused with a saline solution followed by a 4% paraformaldehyde in phosphate buffer. Sagittal brain sections (40 m thick) were prepared as described (Rhodes et al., 1997) . Brain sections were permeabilized with 0.1% Triton X-100 in Tris-buffered saline (TBS, 10 mM Tris, pH 7.5, 0.15 M NaCl). For the diaminobenzidine/nickel ammonium sulfate staining, sections were blocked in a 5% horse serum solution, incubated overnight with L6/60 mAb (0.6 g/ml), and 1 hour in biotinylated horse antimouse secondary antibody (Vector Laboratories, Burlingame, CA). Detection of the antibodyantigen complexes was accomplished using the ABC Elite peroxidase reaction kit (Vector Laboratories) and visualized using the nickel-enhanced diaminobenzidine procedure.
For the immunofluorescence staining, sections were blocked with 10% goat serum solution, then incubated overnight at 4°C with L6/60 mAb (24 g/ml), and 1) mouse mAbs raised against either Kv1. Trimmer, 1991; 1:100) . Sections were then incubated with species-or isotype-specific Alexa-conjugated secondary antibodies (Molecular Probes, Eugene, OR) as described elsewhere (Strassle et al., 2005) . Fluorescent images were taken with a 24-bit color digital camera installed on a Carl Zeiss Axiovert 200M microscope with a 63ϫ, 1.3 numerical aperture lens or 10ϫ, 0.5 numerical aperture lens and Apotome, using Axiovision software.
Experimental localization of Slo1
Experimental lesions of the rat dentate gyrus were performed as described (Monaghan et al., 2001 ). All surgical procedures were approved by the Wyeth-Ayerst Institutional Animal Care and Use Committee and were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Before surgery, animals were deeply anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and secured in a stereotaxic carrier (David Kopf Instruments, Tujunga, CA). For lesions of the dentate gyrus, ibotenic acid (0.1-0.4 l of a 10-g/l solution in 0.1 M sodium phosphate buffer, pH 7.4) was injected directly into the target structure using a 2-l Hamilton (Reno, NV) microsyringe mounted in a Kopf microsyringe microdrive. In some of these animals injections were made at two or three depths, with each injection separated in the dorsoventral axis by 2.5 mm. Animals were used for immunostaining, as described above, except using L6/60 and K13/31 TC supe at 1:10 dilution, after a 7-day postsurgical survival period.
Immunofluorescence staining of cultured neurons
At 11 or 14 days in vitro (DIV), neurons were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) containing 4% sucrose for 20 minutes at 4°C. Cells were blocked with 4% nonfat dry milk powder in TBS (Blotto-TBS) for 30 minutes and then incubated with mouse anti-c-Myc mAb (19E10; antibody purified from ascites fluid grown from hybridomas obtained from American Type Culture Collection, 1 g/ml) for surface labeling of hSlo1. Cells were then incubated in Blotto-TBS containing 0.1% Triton X-100 for 30 minutes at room temperature and probed with mouse mAbs L6/60 (24 g/ml), anti-Myc (1-9E10, ATCC, 1 g/ml), anti-PSD95 (K28/43; Tiffany et al., 2000; Rasband et al., 2002 ; TC supe 1:10), anti-tau (Chemicon Mab3420, 1:2,000) or anti-MAP-2 (Sigma M1406, 1:1,000), or rabbit anti-synapsin I (Sigma S193, 1:1,000). The specimens were incubated with Alexa-conjugated secondary antibodies and 10 g/ml Hoechst 33258 (Molecular Probes). Images were taken with a 24-bit color digital camera installed on a Carl Zeiss Axioskop 2 microscope using Axiovision software (Carl Zeiss, Thornwood, NY). Images were transferred to Adobe PhotoShop software (Adobe Systems, San Jose, CA) as JPEG files.
Immunoblots
Rat and brain membranes were prepared and treated with purified alkaline phosphatase (AP) as previously described (Shi et al., 1994; Murakoshi et al., 1997; Misonou et al., 2004) . In brief, brains from different ages of rats were homogenized in 5 mM phosphate buffer (pH 7.4) containing 320 mM sucrose, 100 mM NaF. The homogenate was centrifuged at 800g for 10 minutes to remove nuclei and unbroken tissues, then centrifuged at 100,000g to prepare a membrane fraction. For alkaline phosphatase digestion, rat brain membrane fractions were washed twice with 5 mM phosphate buffer (pH 7.4) by centrifugation and resuspension in the same buffer to give a final 10 mg/ml protein concentration. Membranes were then diluted with AP buffer (Roche, Nutley, NJ) to yield a final reaction mixture at 1.5 mg/ml protein concentration, to which protease inhibitors, 0.1% SDS, and 0.1 U/l AP were added and incubated for 3 hours at 37°C. Digested and undigested membranes were diluted with the sample buffer for SDS-PAGE. Mouse brain membranes were prepared from brains of Slo1-knockout mice and wildtype littermates (Meredith et al., 2004) . Molecular weight standards were Amersham (Arlington Heights, IL) Rainbow Markers (RPN800) or Sigma Prestained Molecular Weight Markers (SDS-7B). Proteins were separated on 7.5% SDS polyacrylamide gels (SDS-PAGE) and transferred to nitrocellulose membranes and immunoblotted with L6/60 (10 g/ml), anti-Kv2.1 (K89/41 mouse mAb; Antonucci et al., 2001 ; TC supe, 1:2; f), anti-Kv1.4 (K13/31 mouse mAb; Bekele-Arcuri et al., 1996; TC supe 1:2), anti-GluR1 (rabbit polyclonal antibody, Upstate Biotechnology 07-660, 1:1,000), or commercial anti-Slo1 rabbit polyclonal antibodies from Chemicon (AB5228, lot 22040170; 1:2,000) or Alomone Labs (Jerusalem, Israel; APC-021, lot AN-04, 1:500). The blots were incubated with HRP-conjugated secondary antibodies (ICN) followed by enhanced chemiluminescence reagent (Perkin Elmer, Norwalk, CT). Immunoreactive bands were visualized by exposing the blot to X-ray film.
RESULTS
Characterization of mouse anti-Slo1 monoclonal antibodies
We developed a panel of mouse mAbs specific for the mouse Slo1 (mSlo) ␣ subunit, raised against a recombinant fragment (Pyott et al., 2004) corresponding to amino acids 690 -1196 of mSlo (Access. No. AAA39746; Butler et al., 1993) . This large mouse Slo1 fragment, derived from the intracellular C-terminus, is highly conserved in the rat (100% amino acid identity) and human (99% amino acid identity) Slo1 ␣ subunit polypeptides. The resulting mAbs were extensively characterized for their specificity by immunofluorescence staining against recombinant Slo1 expressed in transfected cell lines, and immunoblotting and immunohistochemical staining of brain samples from adult rats. Ultimate validation was provided by analyzing samples from adult wildtype and Slo1-knockout mice (Meredith et al., 2004) . As shown in Figure 1 , in rat and mouse brain samples L6/60 detected a single microheterogeneous protein band with a relative molecular mass (M r ) of ϳ135 kD, consistent with the range of Slo1 isoforms in rat (1180 -1210 amino acids) and mouse (1144 -1209 amino acids). This immunoblot signal is completely absent in the samples from Slo1-deficient mice (Fig. 1) . In parallel immunoblots, we tested commercially available anti-Slo1 antibodies (Table 1 ) against these same samples. Surprisingly, these commercial antibodies recognize prominent bands in addition to the Slo1-sized band recognized by the L6/60 mAb, and the intensity of immunoreactivity to these extraneous bands is not diminished in the samples prepared from the Slo1 knockout mice (Fig. 1) , suggesting that they are not the products of the Slo1/KCMA1 gene. These results demonstrate the exquisite specificity of the L6/60 antibody against Slo1 ␣ subunit molecules in biochemical analyses of brain samples.
To begin to investigate the molecular basis of the observed microheterogeneity in the brain Slo1 pool on SDS gels, we subjected the adult rat brain membranes to alkaline phosphatase (AP) digestion. Treatment with AP led to a marked shift in the M r of the component Slo1 bands ( Fig.  2A) . However, unlike previous results for the Kv2.1 channel (Murakoshi et al., 1997; Misonou et al., 2004) , for which AP treatment leads to a complete loss of microheterogeneity of the brain Kv2.1 pool ( Fig. 2A) , the brain Slo1 population exhibits multiple bands even after extensive Fig. 1 . Specificity of the anti-Slo1 mAb L6/60. Immunoblot analysis of brain membrane fractions from adult rats and wildtype and Slo1-deficient mice. Proteins were fractionated on 7.5% SDS-PAGE and transferred to nitrocellulose membranes and probed with mouse monoclonal (L6/60, 10 g/ml) or rabbit polyclonal anti-Slo1 (Alomone, 1:500; Chemicon, 1:200), or mouse monoclonal anti-Kv2.1 (K89/41, TC supe 1:2) antibodies as noted. Numbers to left denote mobility of prestained molecular weight standards in kD. Fig. 2 . Microheterogeneity of Slo1 in rat brain revealed by L6/60 immunoblot analyses. A: Immunoblot analysis of the effects of alkaline phosphatase (AP) digestion on adult rat brain Slo1. Adult rat brain membranes treated without (-) or with 0.1 U/l AP (ϩ) for 3 hours at 37°C were separated on 7.5% SDS-PAGE and transferred to nitrocellulose membranes, then probed with anti-Kv2.1 (K89/41 mouse mAb, TC supe 1:2), anti-Kv1.4 (K13/31 mouse mAb, TC supe 1:2), anti-GluR1 (rabbit polyclonal antibody, Upstate 1:1000), or antiSlo1 (L6/60, 10 g/ml) antibodies. Slo1 exhibited AP-shifts from M r ϳ135 to ϳ128 kD (bands 1 and 2 indicated on the right). Brain Kv2.1 also shifted in M r upon AP treatment, whereas Kv1.4 and GluR1 did not. B: Immunoblot analysis of developmental rat brain membrane samples. L6/60 (10 g/ml) immunostaining at postnatal day 2 (P2) revealed at least three distinct bands as indicated in the left margin (1, 135 kD; 2, 131 kD; 3, 124 kD), which changed in their relative proportions during postnatal development. A, adult; C, adult sample incubated 3 hours at 37°C without AP; AP, adult sample incubated 3 hours at 37°C with AP. Numbers to left denote mobility of prestained molecular weight standards in kD.
AP treatment (3 hours at 37°C). This suggests that mechanisms outside of differential phosphorylation (e.g., alternative splicing of Slo1 mRNAs; Shipston, 2001) contribute to the microheterogeneity of the Slo1 polypeptide pool in rat brain that is observed on SDS gels. The immunoreactivity of L6/60 to multiple Slo1 isoforms is expected, given that the location of the L6/60 binding site on amino acids 690 -891 of mSlo1 is in an area encoded by an invariant exon encoding a polypeptide segment present in all 16 known mouse and rat Slo1 isoforms.
To address whether the microheterogeneity of Slo1 in rat brain is developmentally regulated, we performed immunoblots on crude membrane prepared from whole brains of different aged rats. This developmental immunoblot analysis revealed further heterogeneity in Slo1 polypeptides, with immunoreactive bands at M r ϳ135, 131, and 124 kD (bands 1, 2, 3, respectively, in Fig. 2B ). The components of the brain Slo1 pool change progressively with development, in that in the first 2 postnatal weeks the M r ϳ131 and 124 kD isoforms predominate, while in adult the M r ϳ135 kD isoform predominates. This suggests that the brain Slo1 polypeptide pool changes with development. However, precise correlation with specific splice variants (e.g., Strex exons) is not possible on the basis of electrophoretic mobility and immunoreactivity.
Immunolocalization of Slo1 in axons and terminal fields in the hippocampus
We next used the L6/60 mAb to evaluate localization of the Slo1 ␣ subunit in rat brain. It has been reported previously that rat Slo1 is localized predominantly in axons and terminal fields of many brain regions, but is also present in certain neuronal somata and dendrites (Knaus et al., 1996; Hu et al., 2001; Grunnet and Kaufmann, 2004) . Consistent with these studies, we found intense staining for Slo1 in the hilus of the dentate gyrus and in the stratum lucidum of CA3, corresponding to the mossy fiber axons of dentate granule cells (Fig. 3A) . Moreover, Slo1 staining was observed in the middle and outer third of the molecular layer of the dentate gyrus, indicating that Slo1 might be present on nerve terminals of perforant path axons. In stratum radiatum and stratum oriens of CA1-CA3 there is a less intensely staining zone of immunoreactivity that corresponds precisely to the termination zone of the Schaffer collateral pathway. There was virtually no labeling on the somata of dentate granule cells and pyramidal neurons in CA1 and CA3 regions (Fig. 3A) .
To further verify specificity of L6/60 antibody, mouse brain sections from wildtype and Slo1-deficient mice were stained with mAb L6/60. L6/60 strongly labeled the hippocampus in sections obtained from the brains of wildtype mice, but not those from Slo1-deficient mice. Figure 3B shows double immunofluorescence staining for Slo1 (red) and the voltage-gated K ϩ channel Kv2.1 (green) in the anterior hippocampal formation in wildtype and Slo1 knockout mice. Kv2.1 is expressed on the somatodendritic membrane of interneurons and pyramidal neurons throughout this regions the hippocampus . In wildtype mice, Slo1 staining is restricted to the mossy fiber axons and terminal fields, where it forms a staining pattern complementary to that of somatodendritic Kv2.1. In Slo1-deficient mice, Slo1 staining is eliminated but Kv2.1 staining is unchanged (Fig. 3B) . Staining for the Kv1.4 channel was also unchanged in the Slo1-deficient mice (not shown). Combined with the fact that no obvious structural abnormalities are apparent by Nissl staining (A.M., unpubl. data) the effects of the Slo1 knockout, at least at the level of these light microscope analyses, appear to be restricted to expression of Slo1 itself. It should be noted that the commercial anti-Slo1 antibodies used for the immunoblotting experiments in Figure 1 did not yield immunohistochemical staining consistent with that of L6/60, or observed in previous studies of Slo1 localization. Moreover, the staining from the commercial anti-Slo1 antibodies was largely unaffected in the Slo1 knockout (data not shown).
Axonal localization of Slo1 was further confirmed by double-labeling immunofluorescence analysis using confocal microscopy. In the CA3 region of hippocampus, L6/60 labeling in stratum lucidum overlapped with staining for Kv1.4 (Fig. 4) , which has been shown previously to be C: Magnified view of mossy fiber axons. Arrows in A-C highlight anatomical landmarks that specify the regions magnified. D,E: Double label immunofluorescence labeling of brain sections from wildtype (D, WT) and Slo1-deficient (E, KO) mice. Brain sections from these mice were stained with L6/60 (24 g/ml) mAb in red, and anti-Kv2.1 (KC rabbit polyclonal, 1:100) antibody in green. Images were taken from the hilus of the dentate gyrus and CA3 stratum lucidum. Scale bars ϭ 500 m in A; 100 m in C (applies to B,C); 50 m in D (applies to D,E).
localized to mossy fiber axons and terminals in studies employing immunoelectron microscopy (Cooper et al., 1998) and experimental lesions of dentate gyrus and CA3 (Monaghan et al., 2001) . In contrast, the Slo1 staining interdigitated with staining for Kv2.1 on the somata and apical dendrites of CA3 pyramidal neurons (Fig. 4) .
To experimentally determine whether the L6/60 staining in stratum lucidum of CA3 was to mossy fiber axons and terminals, we employed the excitotoxin ibotenic acid to generate circumscribed lesions in the dentate gyrus of an individual hippocampus of adult rats. The hippocampus of the nonlesioned hemisphere served as the control. Sections from lesioned and control hemispheres were then stained with L6/60 and other antibodies to determine the effects of the dentate gyrus lesion. As shown in Figure 5 , L6/60 exhibits robust staining to an intense band in stratum lucidum of CA3 in a pattern consistent with localization to mossy fiber terminals and axons. Staining for Fig. 4 . Localization of Slo1 in rat hippocampal mossy fibers. Magnified view of stratum lucidum of CA3 region of hippocampus. A-C: Somata and apical dendrites of CA3 pyramidal neurons were negatively stained with L6/60 (A, 24 g/ml) as well as with antiKv1.4 antibody (B, K13/31 mouse mAb, TC supe 1:2), which overlapped in mossy fibers (C). D-F: in contrast, somatodendritic Kv2.1 (D, KC rabbit polyclonal antibody, 1:100) staining interdigitated with L6/60 staining (E), indicating the presence of Slo1 on synaptic terminals on the Kv2.1-positive apical dendrites of CA3 pyramidal neurons (F, overlay). Scale bar ϭ 10 m in A (applies to A-F). Fig. 5 . Effects of an ibotenic acid lesion on the distribution and density of Slo1 immunoreactivity in the rat hippocampal formation. These photomicrographs show the pattern of immunoreactivity for the indicated subunits in the unoperated, control hemisphere (A-E) and operated hemisphere (F-J) of an animal that sustained a circumscribed unilateral ibotenic acid lesion. This lesion destroyed cells in the distal CA1 subfield, prosubiculum, and subiculum, and also destroyed a central portion of the dentate gyrus. The entire CA3 and proximal CA1 subfield was spared by this lesion. This lesion greatly reduced the density of Slo1 (A,F; L6/60 TC supe 1:10), and Kv1.4 (B,G; K13/31 TC supe 1:10) in stratum lucidum of CA3, but did not affect binding of secondary antibody alone (C,H), nor staining for Slo1 (D,I; L6/60 TC supe 1:10), and Kv1.4 (E,J; K13/31 TC supe 1:10) in the terminal fields of striatal efferents to globus pallidus. Kv1.4 yields a similar pattern. That the staining for Slo1 is associated with axons and nerve terminals is supported by the fact that this staining is absent in sections prepared from the hemisphere in which the dentate gyrus had been lesioned. A similar loss of Kv1.4 staining was observed in the lesioned hemisphere, consistent with previous results (Monaghan et al., 2001) . Intense Slo1 staining is also observed in globus pallidus, presumably in termination zones of striatal efferents, as has also been previously observed for Kv1.4 Rhodes et al., 1997) . The staining for Slo1 and for Kv1.4 in globus pallidus (and in other brain regions) was unaffected by the dentate gyrus lesion. These data showing specific loss of staining in the stratum lucidum of CA3 upon excitotoxic lesion of the dentate gyrus are consistent with a localization of Slo1 on axons and terminals of mossy fiber afferents that emanate from dentate granule cells that are selectively eliminated in the lesioned hemisphere.
Immunolocalization of Slo1 to basket cell axons and terminals in cerebellum
In the cerebellum, we found robust staining of Slo1 in the Purkinje cell and molecular layers (Fig. 6) . Previous studies reported strong Slo1 staining in the somata and dendrites of Purkinje cells (Knaus et al., 1996; Sausbier et al., 2004) . However, higher resolution imaging of this immunostaining with the L6/60 mAb revealed that in addition to robust somatodendritic staining of Purkinje cells, there was also intense labeling in the pinceau of basket cell terminals that surround the axon initial segments of Purkinje cells (Fig. 6) . That the previously reported somatodendritic staining in Purkinje cells is less intense than staining on the basket cell terminals is shown by both immunofluorescence staining and also by comparing results obtained using different development times in immunoperoxidase staining experiments (Supplemental Fig.  1 ). Figure 6B shows that the Slo1 staining in basket cell terminals, in Purkinje cells somata, and in the molecular layer is eliminated in the cerebella of Slo1 knockout mice, consistent with the specific nature of the staining.
To further investigate the localization of Slo1 in cerebellar cortex, double-label immunofluorescence staining was combined with confocal microscopy. L6/60 consistently labeled the basket cell nerve terminals synapsing on Purkinje cells (Fig. 7A) , where it exhibited strong overlap with intense staining for the Kv1.2 channel (McNamara et al., 1993; Rhodes et al., 1997) . However, L6/60 staining did not precisely overlap, and in fact encircled staining for neurofascin 155/186 (NF-155) (Fig. 7B ) that labeled the axon initial segments of Purkinje cells (Boiko et al., 2001; Ango et al., 2004) . These high-resolution confocal images also provide further support for expression of Slo1 on the somata and dendrites of Purkinje cells, as shown by double staining with calbindin (Fig. 7C) , a Ca 2ϩ -binding protein expressed at high levels in Purkinje cells (Ango et al., 2004) , and for somatodendritic Kv2.1 (Fig.  7D ).
Axonal and presynaptic localization of endogenous Slo1, and exogenous recombinant human Slo1, in cultured rat hippocampal pyramidal neurons
To investigate whether exogenously expressed recombinant Slo1 ␣ subunits would display a polarized localization in neurons, as observed in polarized epithelial cells (Bravo-Zehnder et al., 2000) , we transfected primary cultures of rat hippocampal neurons (Lim et al., 2001 ). This Brain sections from these mice were stained with L6/60 mAb (24 g/ml) in red, and anti-Kv2.1 (KC rabbit polyclonal, 1:100) antibody in green. Images were taken from the Purkinje cell layer and reveal that staining in Purkinje cell somata, basket cell terminals, and the molecular layer is eliminated in the Slo1 knockout. Scale bars ϭ 100 m in A; 500 m in B,C; 10 m for D.
culture system provides a relatively homogenous population of pyramidal neurons (ϳ90%), which spontaneously form synaptic connections. These cultured rat hippocampal pyramidal neurons express endogenous Slo1, as judged by immunofluorescence staining of the soma, and of MAP-2 negative processes, presumably axons, with the L6/60 antibody (Fig. 8A) . MAP-2 positive processes, presumably dendrites, also exhibit detectable L6/60 staining.
To determine the localization of exogenous Slo1 in these cultured neurons, neurons were transfected with a human Slo1 (hSlo) cDNA (Access. No. AAB65837, human isoform 5) containing an extracellular N-terminal Myc tag (Meera et al., 1997) , at 8 days in vitro (DIV) and cultured until 11 DIV. We initially stained permeabilized neurons with L6/60 antibody (Fig. 8B ) and anti-Myc antibody (data not shown) and found that a majority of hSlo1 was localized in the somata and proximal dendrites of transfected neurons, presumably in the rough endoplasmic reticulum (ER), as this perinuclear staining overlapped with the staining for BiP, a resident protein of this organelle (data not shown). However, surface labeling of hSlo1 in nonpermeabilized neurons with anti-Myc antibody (Supplemental Fig. 2 ) revealed surface expression of hSlo1 and showed that the major surface pool of hSlo1 resides on the axonal membrane, where staining overlaps with that of the axonal marker, tau (Fig. 8C) , and does not overlap with the dendritic marker MAP-2 (Fig. 8D) . Note the staining of myc-positive axons enveloping a presumably untransfected neuron (arrow) to the upper left of the transfected neuron in Figure 8B , reinforcing the notion that even the punctate staining on the somata and dendrites of cultured neurons may be due to Slo1 localization on afferent axons and terminals.
We further analyzed the localization of this surface pool of hSlo1 in cultured neurons. To examine whether surface hSlo1 localizes at the synaptic terminals as in the hippocampus in situ, neurons were double-labeled with antiMyc and anti-synapsin I antibodies under nonpermeabilized and permeabilized conditions, respectively. At 11 DIV (i.e., 3 days after transfection), neurons expressing hSlo1 showed cell surface Myc-positive axonal processes projecting to neighboring cells. Although the surface Myc staining appeared as a punctate pattern on these processes, most of the puncta at 11 DIV did not overlap with synapsin-I positive puncta (Fig. 9A) . By 14 DIV, a substantial subset of these cell-surface Myc-positive puncta were now found colocalized with the synapsin-I positive puncta (Fig. 9A,B) . However, even at 14 DIV a subpopulation of Myc-positive puncta did not colocalize with synapsin-I staining, indicating certain clusters of hSlo1 on the axonal membrane may represent immature nerve terminals without synapsin-I staining, similar to those that predominate at 11 DIV. While none of the surface Mycpositive puncta overlapped with postsynaptic staining of PSD-95 (Fig. 9B ), some were opposed to PSD-95 puncta (arrows in Fig. 9B ). These results suggest that axonal Slo1 channels become accumulated in presynaptic terminals as synapses mature in cultured neurons.
DISCUSSION
A determination of the precise localization of ion channel proteins is crucial to understanding their specific contribution to neuronal function, especially in the context of the extreme morphological complexity of mammalian central neurons . The distribution of Slo1 ␣ subunits in mammalian brain has been studied previously by analyses of mRNA expression using in situ hybridization (Knaus et al., 1996; Chang et al., 1997) and immunostaining using polyclonal antibodies (Table 1) raised against synthetic peptides (Knaus et al., 1996; Hu et al., 2001; Grunnet and Kaufmann, 2004; Martin et al., 2004) or fusion proteins (Sausbier et al., 2004) corresponding to segments from the Slo1 ␣ subunit intracellular C-terminus. These studies revealed that Slo1 ␣ subunits are expressed widely in rat brain but highly accumulated in axons and nerve terminals of principal neurons, a pattern that is most clearly observed in the hippocampus (Knaus et al., 1996) . We have now generated an anti-Slo1 mAb, L6/60, that has been extensively characterized against recombinant Slo1 ␣ subunits expressed in mammalian cell lines, and against brain samples from rats, and from wildtype and Slo1-deficient mice. Utilizing the L6/60 mAb in conjunction with mAbs for Kv channels and other neuronal proteins that show defined patterns of distribution in the hippocampus and cerebellum (Rhodes et al., 1997) , and excitotoxic lesion studies (Monaghan et al., 2001) , we further confirm the axonal and synaptic localization of the Slo1 ␣ subunit. Consistent with these previous studies, our results showed that Slo1 ␣ subunits Fig. 8 . Axonal localization of endogenous Slo1, and exogenous recombinant human Slo1, (hSlo1) in cultured rat hippocampal pyramidal neurons. A-C: Localization of endogenous Slo1. Neurons at 24 DIV were fixed, permeabilized with 0.1% Triton X-100, and stained with anti-Slo1 antibody L6/60 (A: 24 g/ml; green) to detect the total pool of endogenous rSlo1, and anti-MAP2 (B: Sigma mouse mAb, 1:1,000; C: overlay). D-F: Localization of surface hSlo1. Neurons at 11 DIV were fixed, stained with anti-Myc antibody (E: mouse monoclonal 1-9E10, 1 g/ml) for cell surface hSlo1 (green), and then permeabilized with 0.1% Triton X-100 for L6/60 (D: 5 g/ml) staining (red) to detect the total pool of exogenous hSlo1 and endogenous rSlo1 (F: overlay). Arrow points to a presumably untransfected neuron in the culture. D, inset: hSlo in both axons and dendrites was detected on a longer exposure. G: Surface Myc-positive (mouse mAb 1-9E10, 1 g/ ml) processes overlap with axonal tau (Sigma mouse monoclonal antibody 1:2,000) staining. are expressed throughout the hippocampus and are localized to areas corresponding to axons and synaptic terminal zones, and are especially prominent in mossy fiber axons and terminals. The specificity of this staining is shown by the fact that it is eliminated in Slo1-deficient mice, and in rats that have been subjected to experimental lesion of dentate granule cells, the source of mossy fibers.
SLO1 CHANNEL LOCALIZATION IN NEURONS
Moreover, we provide compelling data that in cerebellum Slo1 exhibits prominent expression in the presynaptic terminals of cerebellar basket cells. This is in addition to lower levels of somatodendritic Slo1 expression in Purkinje cells, as shown in previous immunocytochemical studies (Knaus et al., 1996; Grunnet and Kaufmann, 2004; Sausbier et al., 2004) , and as suggested by electrophysiological studies of somatodendritic BK channels (e.g., Edgerton and Reinhart, 2003; Womack and Khodakhah, 2004) . The high level of expression in basket cell terminals was substantiated using confocal immunofluorescence microscopy combined with double labeling with specific antibodies for marker proteins of different subcellular compartments (Rhodes et al., 1997; Ango et al., 2004) . In situ hybridization experiments have shown that in cerebellum Slo1 mRNA is predominantly expressed in the Purkinje cell layer (Knaus et al., 1996; Chang et al., 1997) . However, expression of Slo1 mRNA in basket cells, which lie close to the Purkinje cell layer, may be difficult to determine (Ango et al., 2004) , such that Slo1 mRNA expression in basket cell somata could be masked by that in large cell bodies of Purkinje neurons in the in situ hybridization analyses. Slo1 KO mice are ataxic (Meredith et al., 2004; Sausbier et al., 2004) , a phenotype that Sausbier et al. (2004) attributed to the lack of BK channels in Purkinje cells. However, the role of BK channels in the presynaptic terminals of basket cells may need to be considered to fully understand cerebellar dysfunction in Slo1 knockout mice. Sausbier et al. (2004) found severe suppression of intrinsic Purkinje cell activity in Slo1-knockout mice. As basket cell terminals provide inhibitory drive to Purkinje cells, deletion of BK channels from these sites, and the resultant hyperexcitability of the GABAergic basket cell terminals, could further contribute to the suppressed intrinsic excitability of Purkinje cells and the ataxia observed in the Slo1-null mice. Such a model is consistent with results from Kv1.1 knockout mice, where loss of Kv1.1 from basket cell terminals increases GABA release to an extent sufficient to generate an ataxic phenotype due to suppression of Purkinje cell excitability (Zhang et al., 1999) .
We show here that the validated anti-Slo1 L6/60 mAb recognizes multiple species of Slo1 in crude rat brain membrane preparations. Slo1 is subjected to alternative splicing to generate at least 11 isoforms in rats (NCBI Access. No. Q62976) and five isoforms in mouse (NCBI Access. No. Q08460). Moreover, some of these isoforms exhibit distinct patterns of phosphorylation, biophysical and trafficking properties, and expression (reviewed in Shipston, 2001 ). The binding site for L6/60 is in a region (aa 690 -891 of mouse isoform 2) that is intact in all rat and mouse Slo1 isoforms; thus, it is not surprising that this monospecific Slo1 mAb exhibits reactivity to multiple Slo1 species. That some of the heterogeneity of the L6/60-positive Slo1 pool is generated from alternative splicing is suggested by the fact that the observed microheterogeneity remains after exhaustive in vitro dephosphorylation of Slo1 with alkaline phosphatase. Our immunoblot analysis of samples prepared from the brains of different aged rats suggests that the alternative splicing may be developmentally regulated in brain. Anti-Slo1 mAbs that bind to discrete sites within isoform-specific polypeptide segments encoded by alternatively spliced Slo1 exons may allow for dissection of the brain Slo1 polypeptide pool. We have presented here the first study using experimental excitotoxic lesions and knockout animals to definitively address the localization of Slo1 protein in mammalian brain. We previously employed excitotoxic lesions in rat hippocampus to define the predominant subcellular localization of Kv1 channel ␣ subunits to axons and presynaptic terminals (Monaghan et al., 2001) , and of Kv2.1 and Kv4 ␣ subunits to dendrites . Using antibodies to these channels as markers, we found here that ibotenic acid lesions in dentate gyrus eliminated anti-Slo1 L6/60 mAb staining in stratum lucidum of CA3, consistent with a localization of Slo1 on axons and terminals of dentate granule cell mossy fibers, and not on dendrites of CA3 pyramidal neurons. These results are consistent with previous interpretation of light microscopic analyses of immunoperoxidase staining (Knaus et al., 1995; Grunnet and Kaufmann, 2004) . Moreover, the presynaptic localization of Slo1 in mossy fiber terminals is similar to that defined in immunogold electron microscopic localization of Slo1 immunoreactivity to presynaptic terminals of another hippocampal circuit, the CA3-derived Schaffer collaterals that terminate in stratum radiatum of hippocampal CA1 (Hu et al., 2001) . There is little doubt that Slo1/BK channels are found in somatodendritic membranes of most neurons, including cerebellar Purkinje cells neurons (e.g., Edgerton and Reinhart, 2003; Womack and Khodakhah, 2004) , neocortical pyramidal neurons (Benhassine and Berger, 2005) , and hippocampal CA1 pyramidal cells (Golding et al., 1999) . The lack of detectable L6/60 staining in somatodendritic domains of adult hippocampal pyramidal neurons may reflect a substantially lower density of Slo1 protein here relative to that on axons and terminals, the presence of an as-yet unknown splice variant that lacks L6/60 binding, or occlusion of L6/60 binding by protein-protein interactions or other posttranslational modifications specific to the somatodendritic compartment.
We have expressed recombinant hSlo1 in cultured rat hippocampal neurons and shown that the exogenous hSlo1 ␣ subunit was abundantly expressed on the axonal surface membrane, and that these surface hSlo1 channels became accumulated in presynaptic terminals as neuronal circuits mature in vitro. Although we can easily detect surface hSlo1 molecules expressed in these cultured hippocampal neurons, a large fraction of the translated hSlo1 was retained in the ER, as observed for endogenous Slo1 in these cultures, and as previously observed for wildtype hSlo1 expression in other nonneuronal heterologous systems (Bravo-Zehnder et al., 2000; Ling et al., 2003; Kwon and Guggino, 2004) . We also observed somatodendritic staining of endogenous Slo1, and exogenous surface hSlo1 in these transfected neurons, suggesting that polarized expression of exogenous hSlo1 in neurons is not as tightly regulated as in epithelial cells (Bravo-Zehnder et al., 2000) or that overexpression of this protein normally found predominantly on axons and presynaptic terminals may overwhelm the axonal trafficking system, as has been observed for axonal Kv channels (Arnold and Clapham, 1999) and metabotropic glutamate receptors (Stowell and Craig, 1999) expressed exogenously in cultured neurons. That the level of surface hSlo1 staining in axons was clearly stronger than that in the somatodendritic region indicates that the prominent polarized localization of Slo1 in axons as observed in hippocampus was still established and maintained to a certain extent for exogenous hSlo1 in cultured neurons.
The Slo1 ␣ subunit has a large cytoplasmic C-terminus that has been shown to be important for surface expression of Slo1 ␣ subunit in heterologous expression system such as polarized Madin-Darby canine kidney (MDCK) cells (Bravo-Zehnder et al., 2000) . This cytoplasmic tail also contains a signal for apical localization of a unique rabbit renal Slo1 isoform (NCBI Access. No. AF201702) in polarized mouse kidney cells (Kwon and Guggino, 2004) . In most cases the apical membrane of polarized epithelial cells is analogous to the axonal membrane of neurons (and the basolateral to the somatodendritic; Dotti and Simons, 1990) , although there are several axonal proteins which do not "behave" (Trimmer, 1999; Trimmer and Rhodes, 2004) . As the identified minimal sequence of the apical localization signal of the rabbit renal Slo1 (NAGQSRA) does not exhibit similarity to known trafficking and sorting signals (Kwon and Guggino, 2004) , the molecular mechanisms of the polarized localization remains to be examined, especially in neuronal cells. It is intriguing that the NAGQSRA apical localization signal is found in all mouse and rat Slo1 isoforms.
